The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Systematic review of treatments for atopic eczema.
Open accessAbstract
BACKGROUND: Atopic eczema is the commonest inflammatory skin disease of childhood, affecting 15-20% of children in the UK at any one time. Adults make up about one-third of all community cases. Moderate-to-severe atopic eczema can have a profound effect on the quality of life for both sufferers and their families. In addition to the effects of intractable itching, skin damage, soreness, sleep loss and the social stigma of a visible skin disease, other factors such as frequent visits to doctors, special clothing and¿the need to constantly apply messy topical applications all add to the burden of disease. The cause of atopic eczema is unknown, though a genetic pre-disposition and a combination of allergic and non-allergic factors appear to be important in determining disease expression. Treatment of atopic eczema in the UK is characterised by a profusion of treatments aimed at disease control. The evidential basis of these treatments is often unclear. Most people with atopic eczema are managed in primary care where the least research has been done. OBJECTIVES: The objectives of this scoping review are two-fold. To produce an up-to-date coverage 'map' of randomised controlled trials (RCTs) of treatments of atopic eczema. To assist in making treatment recommendations by summarising the available RCT evidence using qualitative and quantitative methods. DATA SOURCES: Data sources included electronic searching of MEDLINE, EMBASE, the Cochrane Controlled Clinical Trials Register, the Cochrane Skin Group specialised register of trials, hand-searching of atopic eczema conference proceedings, follow-up of references in retrieved articles, contact with leading researchers and requests to relevant pharmaceutical companies. INCLUSION/EXCLUSION CRITERIA: Only RCTs of therapeutic agents used in the prevention and treatment of people with atopic eczema of any age were considered for inclusion. Only studies where a physician diagnosed atopic eczema or atopic dermatitis were included. DATA EXTRACTION: Data extraction was conducted by two observers onto abstraction forms, with discrepancies resolved by discussion. QUALITY ASSESSMENT: The quality assessment of retrieved RCTs included an assessment of: a clear description of method and concealment of allocation of randomisation, the degree to which assessors and participants were blinded to the study interventions, and whether all those originally randomised were included in the final main analysis. DATA SYNTHESIS: Where possible, quantitative pooling of similar RCTs was conducted using the Cochrane Collaboration's methods. Where statistical heterogeneity was found, sources of heterogeneity in terms of study participants, formulation or posology of intervention, and use of co-treatments were explored. Where pooling was not deemed to be appropriate, detailed descriptions of the study characteristics and main reported results were presented along with comments on study quality. RESULTS: A total of 1165 possible RCTs were retrieved in hard copy form for further scrutiny. Of these, 893 were excluded from further analysis because of lack of appropriate data. The 272 remaining RCTs of atopic eczema covered at least 47 different interventions, which could be broadly categorised into ten main groups. Quality of reporting was generally poor, and limited statistical pooling was possible only for oral cyclosporin, and only then after considerable data transformation. There was reasonable RCT evidence to support the use of oral cyclosporin, topical corticosteroids, psychological approaches and ultraviolet light therapy. There was insufficient evidence to make recommendations on maternal allergen avoidance for disease prevention, oral antihistamines, Chinese herbs, dietary restriction in established atopic eczema, homeopathy, house dust mite reduction, massage therapy, hypnotherapy, evening primrose oil, emollients, topical coal tar and topical doxepin. (ABSTRACT TRUNCATED)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hay fever, hygiene, and household size.
Strachan, D. P. (1989) · BMJ · doi:10.1136/bmj.299.6710.1259 · Cited by 5,054
Sampson, H. A., & Ho, D. G. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70133-7 · Cited by 1,055
Probiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918
Marshall, M., Lockwood, A., Bradley, C., Adams, C., Joy, C., & Fenton, M. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.3.249 · Cited by 870
Estimation of a Common Effect Parameter from Sparse Follow-Up Data
Greenland, S., & Robins, J. M. (1985) · Biometrics · doi:10.2307/2530643 · Cited by 794
Zeiger, R. S., & Heller, S. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70074-9 · Cited by 539
A Short-Term Trial of Tacrolimus Ointment for Atopic Dermatitis
Ruzicka, T., Bieber, T., Schöpf, E., Rubins, A., Dobozy, A., Bos, J. D., Jablonska, S., Ahmed, I., Thestrup-Pedersen, K., Daniel, F., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371203 · Cited by 518
Chren, M.-M. (1997) · Archives of Dermatology · doi:10.1001/archderm.1997.03890470111018 · Cited by 480
Chren, M. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.11.1433 · Cited by 446
Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis
Tan, B. B., Weald, D., Strickland, I., & Freidmann, P. S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91556-1 · Cited by 426
Atopic eczema: its impact on the family and financial cost
Su, J. C., Kemp, A. S., Varigos, G. A., & Nolan, T. M. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.76.2.159 · Cited by 425
Sowden, J. M., Allen, B. R., Berth-Jones, J., Graham-Brown, R. A. C., Motley, R. J., Finlay, A. Y., Salek, M., Marks, R., Ross, J. S., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411
Fleiss, J. L., & Gross, A. J. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90261-7 · Cited by 404
Moher, Cook, Jadad, Tugwell, Moher, Jones, Pham, & Klassen (1999) · Health Technology Assessment · doi:10.3310/hta3120 · Cited by 368
A DOUBLE-BLIND CONTROLLED CROSSOVER TRIAL OF AN ANTIGEN-AVOIDANCE DIET IN ATOPIC ECZEMA
Atherton, D. J., Soothill, J. F., Sewell, M., Wells, R. S., & Chilvers, C. D. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91199-6 · Cited by 337
Is the prevalence of atopic dermatitis increasing?
WILLIAMS, H. C. (1992) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1992.tb00244.x · Cited by 313
Ehlers, A., Stangier, U., & Gieler, U. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.63.4.624 · Cited by 311
Boguniewicz, M., Fiedler, V. C., Raimer, S., Lawrence, I. D., Leung, D. Y. M., & Hanifin, J. M. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70281-7 · Cited by 309
Allergen avoidance in infancy and allergy at 4 years of age
Hide, D. W., Matthews, S., Tariq, S., & Arshad, S. H. (1996) · Allergy · doi:10.1111/j.1398-9995.1996.tb00040.x · Cited by 296
Recombinant interferon gamma therapy for atopic dermatitis
Hanifin, J. M., Schneider, L. C., Leung, D. Y. M., Ellis, C. N., Jaffe, H. S., Izu, A. E., Bucalo, L. R., Hirabayashi, S. E., Tofte, S. J., Cantu-Gonzales, G., et al. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70026-p · Cited by 289
Lucas, A., Brooke, O. G., Morley, R., Cole, T. J., & Bamford, M. F. (1990) · BMJ · doi:10.1136/bmj.300.6728.837 · Cited by 283
High-dose UVA1 therapy in the treatment of patients with atopic dermatitis
Krutmann, J., Czech, W., Diepgen, T. L., Niedner, R., Kapp, A., & Schöpf, E. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70031-a · Cited by 280
Sampson, H. A., Broadbent, K. R., & Bernhisel-Broadbent, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907273210405 · Cited by 279
ORAL EVENING-PRIMROSE-SEED OIL IMPROVES ATOPIC ECZEMA
Wright, S., & Burton, J. L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92784-2 · Cited by 278
Tacrolimus Ointment does not Affect Collagen Synthesis: Results of a Single-Center Randomized Trial
Reitamo, S., Rissanen, J., Remitz, A., Granlund, H., Erkko, P., Autio, P., Lauerma, A. I., & Elg, P. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00323.x · Cited by 273
A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema
SHEEHAN, M. P., & ATHERTON, D. J. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb07817.x · Cited by 262
Childhood eczema: disease of the advantaged?
Williams, H. C., Strachan, D. P., & Hay, R. J. (1994) · BMJ · doi:10.1136/bmj.308.6937.1132 · Cited by 257
Fälth-Magnusson, K., & Max Kjeltman, N.-I. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90378-f · Cited by 240
Effect of allergen avoidance in infancy on allergic manifestations at age two years
Hide, D. W., Matthews, S., Matthews, L., Stevens, M., Ridout, S., Twiselton, R., Gant, C., & Arshad, S. H. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90375-1 · Cited by 229
Effectiveness of the Ascomycin Macrolactam SDZ ASM 981 in the Topical Treatment of Atopic Dermatitis
Van Leent, E. J. M., Gräber, M., Thurston, M., Wagenaar, A., Spuls, P. I., & Bos, J. D. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.7.805 · Cited by 223
Isolauri, E., Sütas, Y., Mäkinen-Kiljunen, S., Oja, S. S., Isosomppi, R., & Turjanmaa, K. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70111-7 · Cited by 221
SALEK, M. S., FINLAY, A. Y., LUSCOMBE, D. K., ALLEN, B. R., BERTH-JONES, J., CAMP, R. D. R., GRAHAM-BROWN, R. A. C., KHAN, G. K., MARKS, R., MOTLEYJ, R. J., et al. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb03170.x · Cited by 217
High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trial
Krutmann, J., Diepgen, T. L., Luger, T. A., Grabbe, S., Meffert, H., Sönnichsen, N., Czech, W., Kapp, A., Stege, H., Grewe, M., et al. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70123-9 · Cited by 212
Extensively and partially hydrolysed infant formulas for allergy prophylaxis
Oldaeus, G., Anjou, K., Bjorksten, B., Moran, J. R., & Kjellman, N.-I. M. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.4 · Cited by 205
Outcome Measures of Disease Severity in Atopic Eczema
Charman, C., & Williams, H. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.6.763 · Cited by 203
Emerson, Williams, & Allen (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02316.x · Cited by 188
Self-citationMarini, A., Agosti, M., Motta, G., & Mosca, F. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14267.x · Cited by 186
Lever, R., MacDonald, C., Waugh, P., & Aitchison, T. (1998) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.1998.tb00294.x · Cited by 184
Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study
JOOST, T., HEULE, F., KORSTANJE, M., BROEK, M. J. T. B., STENVELD, H. J., & VLOTEN, W. A. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb13111.x · Cited by 183
CHANDRA, R. K., PURI, S., SURAIYA, C., & CHEEMA, P. S. (1986) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1986.tb01995.x · Cited by 177
Chandra, R. K., Singh, G., & Shridhara, B. (1989) · PubMed · Cited by 169
Local steroid therapy and bacterial skin flora in atopic dermatitis
STALDER, J. F., FLEURY, M., SOURISSE, M., ROSTIN, M., PHELINE, F., & LITOUX, P. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08556.x · Cited by 164
Atopic dermatitis and birth factors: historical follow up by record linkage
Olesen, A. B., Ellingsen, A. R., Olesen, H., Juul, S., & Thestrup-Pedersen, K. (1997) · BMJ · doi:10.1136/bmj.314.7086.1003 · Cited by 161
KJELLMAN, N. ‐. M., & JOHANSSON, S. G. O. (1979) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1979.tb02493.x · Cited by 160
Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis
Berth-Jones, J., & Graham-Brown, R. A. C. (1993) · The Lancet · doi:10.1016/0140-6736(93)90697-f · Cited by 159
Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis
Bjørneboe, A., Søyland, E., Bjørneboe, G. A., Rajka, G., & Drevon, C. A. (1987) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1987.tb04926.x · Cited by 155
Thymopentin therapy reduces the clinical severity of atopic dermatitis
Leung, D. Y. M., Hirsch, R. L., Schneider, L. C., Moody, C., Takaoka, R., Li, S. H., Meyerson, L. A., Mariam, S. G., Goldstein, G., & Hanifin, J. M. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(90)90079-j · Cited by 151
Renz, H., Jujo, K., Bradley, K., et al. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616114 · Cited by 149
The long-term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease
Vandenplas, Y., Hauser, B., den Borre, C. V., Clybouw, C., Mahler, T., Hachimi-Idrissi, S., Deraeve, L., Malfroot, A., & Dab, I. (1995) · European Journal of Pediatrics · doi:10.1007/bf02029362 · Cited by 144
Respiratory reactions provoked by double-blind food challenges in children.
James, J., Bernhisel-Broadbent, J., & Sampson, H. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.1.8111598 · Cited by 141
Schalin, M., Mattila, L., Jansén, C. T., & Uotila, P. J. (1987) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1987.tb04085.x · Cited by 136
Prevalence of atopic eczema in the community: the Lothian Atopic Dermatitis study.
Herd, R. M., Tidman, M. J., Prescott, R. J., & Hunter, J. A. A. (1996) · PubMed · Cited by 135
Adverse reactions to food additives in children with atopic symptoms
Fuglsang, G., Madsen, C. B., Halken, S., Jørgensen, M., Østergaard, P. A., & ØSterballe, O. (1994) · Allergy · doi:10.1111/j.1398-9995.1994.tb00770.x · Cited by 130
Behavioural treatment of scratching in patients with atopic dermatitis
Melin, L., FREDERIKSEN, T., Norén, P., & SWEBILIUS, B. G. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb06241.x · Cited by 127
Körting, H. C., Zienicke, H., Sch�fer-Korting, M., & Braun‐Falco, O. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315408 · Cited by 123
Atopic Dermatitis Symptoms Decreased in Children Following Massage Therapy
Schachner, L. A., Field, T., Hernandez‐Reif, M., Duarte, A. M., & Krasnegor, J. (1998) · Pediatric Dermatology · doi:10.1046/j.1525-1470.1998.1998015390.x · Cited by 123
Long-term prevention of allergic diseases by using protein hydrolysate formula in at-risk infants
Mallet, E., & Hénocq, A. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81415-5 · Cited by 119
Parental education in the treatment of childhood atopic eczema.
Broberg, A., Kalimo, K., Lindblad, B., & Swanbeck, G. (1990) · Acta Dermato Venereologica · doi:10.2340/00015555-70495499 · Cited by 117
Preventive effect of bedding encasement with microfine fibers on mite sensitization
Nishioka, K., Yasueda, H., & Saito, H. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70189-7 · Cited by 114
Measurement of disease activity and outcome in atopic dermatitis
Finlay, A. Y. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-1031.x · Cited by 111
Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema
Henz, Jabłońska, Kerkhof, V. D., Stingl, Błaszczyk, VANDERVALK, VEENHUIZEN, Muggli, & RAEDERSTORFF (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02771.x · Cited by 110
Jang, I. G., Yang, J.-K., Lee, H.-J., Yi, J., Kim, H.-O., Kim, C. W., & Kim, T.-Y. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104793 · Cited by 109
Sanda, T., Yasue, T., OOHASH, M., & Yasue, A. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90370-h · Cited by 109
Fung, A. Y. P., Look, P. C. N., Mrcpi, Fhkam, Chong, L., Fhkam, But, P. P. H., Wong, E., & A, M. (1999) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1999.00732.x · Cited by 104
Effect of maternal dietary exclusion on breast fed infants with eczema: two controlled studies.
Cant, A. J., Bailes, J. A., Marsden, R. A., & Hewitt, D. M. (1986) · BMJ · doi:10.1136/bmj.293.6541.231 · Cited by 101
Flucloxacillin in the treatment of atopic dermatitis
Ewing, Ashcroft, Gibbs, Jones, Connor, & David (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02271.x · Cited by 100
Failure of terfenadine in relieving the pruritus of atopic dermatitis
Berth‐Jones, J., & GRAHAM-BROWN, R. A. C. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb08196.x · Cited by 96
Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults.
Hannuksela, M., Kalimo, K., Lammintausta, K. H., Mattila, T., Turjanmaa, K., Varjonen, E., & Pj, C. (1993) · PubMed · Cited by 95
Søyland, E., Funk, J., Rajka, G., Sandberg, M., Thune, P., Rustad, L., HELLAND, S., Middelfart, K., Odu, S., Falk, E. S., et al. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb03414.x · Cited by 94
Wachs, G. N., & Maïbach, H. I. (1976) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1976.tb07021.x · Cited by 88
Evening primrose oil (Efamol) in the treatment of children with atopic eczema.
Bordoni, A., Biagi, F., Masi, M., Ricci, G., Fanelli, C., Patrizi, A., & Ceccolini, E. (1988) · PubMed · Cited by 87
Treatment of itching in atopic eczema with antihistamines with a low sedative profile.
Doherty, V. R., Sylvester, D. G., Kennedy, C., Harvey, S., Calthrop, J. G., & Gibson, J. R. (1989) · BMJ · doi:10.1136/bmj.298.6666.96 · Cited by 83
Epogam evening primrose oil treatment in atopic dermatitis and asthma.
Hederos, C., & Berg, A. (1996) · Archives of Disease in Childhood · doi:10.1136/adc.75.6.494 · Cited by 82
Norén, P., & Melin, L. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01430.x · Cited by 81
Double-blind study of cetirizine in atopic eczema in children.
Rosa, M. L., Ranno, C., Musarra, I., Guglielmo, F., Corrias, A., & Bellanti, J. A. (1994) · PubMed · Cited by 77
Biochemical and immunologic mechanisms in atopic dermatitis: New targets for emerging therapies
Hanifin, J. M., & Chan, S. C. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70410-x · Cited by 77
Treatment of severe atopic dermatitis in childhood with cyclosporin
Zaki, I., Emerson, R. M., & Allen, B. R. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb00705.x · Cited by 75
Diagnostic criteria for atopic dermatitis
Williams, H. C. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65466-9 · Cited by 73
Leroy, B. P., Boden, G., Lachapelle, J. M., Jacquemin, M. G., & Saint-Remy, J.-M. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70033-p · Cited by 72
Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis
Lietman, P. S., Estelle, F., Simons, R., Simons, K. J., Becker, A. B., & Haydey, R. P. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80608-3 · Cited by 71
Inadequate size of 'negative' clinical trials in dermatology
Williams, H. C., & Seed, P. T. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb00178.x · Cited by 67
Infant feeding and subsequent risk of atopic eczema.
Moore, W. J., Midwinter, R. E., Morris, A. F., Colley, J. R., & Soothill, J. F. (1985) · Archives of Disease in Childhood · doi:10.1136/adc.60.8.722 · Cited by 66
Effect of n‐3 fatty acid supplement to patients with atopic dermatitis
Bjørneboe, A., Søyland, E., Bjørneboe, G. A., Rajka, G., & Drevon, C. A. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb01462.x · Cited by 65
Efficacy Trial of Bioresonance in Children with Atopic Dermatitis
Schöni, M. H., Nikolaizik, W. H., & Schöni-Affolter, F. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237460 · Cited by 61
Gehring, W., Bopp, R., Rippke, F., & Gloor, M. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300475 · Cited by 58
Devlin, J. G., & David, T. J. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.6.709 · Cited by 57
Hanifin, J. M., Hebert, A. A., Mays, S. R., Paller, A. S., Sherertz, E. F., Wagner, A. M., Tuley, M. R., & Baker, M. D. (1998) · Current Therapeutic Research · doi:10.1016/s0011-393x(98)85076-5 · Cited by 56
Burks, A. W., & Sampson, H. A. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90910-4 · Cited by 54
Prevalence of atopic eczema in the community: the Lothian atopic dermatitis study
HERD, R. M., Tidman, M. J., Prescott, R. J., & Hunter, J. A. A. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb03600.x · Cited by 53
Galli, E., Chini, L., Nardi, S., Benincori, N., Panei, P., Fraioli, G., Moschese, V., & Rossi, P. (1994) · PubMed · Cited by 52
Modulation by Chinese herbal therapy of immune mechanisms in the skin of patients with atopic eczema
Xu, X.-J., BANERJEE, P., Rustin, M. H. A., & Poulter, L. W. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.d01-1142.x · Cited by 51
Comparison of Two Formulations of Cyclosporin A in the Treatment of Severe Atopic Dermatitis
Zurbriggen, B., Wüthrich, B., Cachelin, A. B., Wili, P. B., & Kägi, M. K. (1999) · Dermatology · doi:10.1159/000018065 · Cited by 47
Colloff, M. J., LEVER, R. S., & McSharry, C. P. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01799.x · Cited by 46
Antigen-free diet in adult patients with atopic dermatitis. A double-blind controlled study
Munkvad, M., Danielsen, L., Høj, L., Povlsen, C. O., Secher, L., Svejgaard, E. L., Bundgaard, A., & Larsen, P. (1984) · Acta Dermato Venereologica · doi:10.2340/0001555564524528 · Cited by 45
Postnatal somatic and mental development after periconceptional multivitamin supplementation.
Czeizel, A. E., & Dobó, M. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.70.3.229 · Cited by 42
Sheehan-Dare, R. A., Goodfield, M. J. D., & Rowell, N. R. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01401.x · Cited by 40
The effect on atopic dermatitis of supplementation with selenium and vitamin E.
Fairris, G. M., Perkins, P., Lloyd, B. B., Hinks, L. J., & Clayton, B. E. (1989) · PubMed · Cited by 39
Ebata, Izumi, Aizawa, Kamide, & Niimura (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02174.x · Cited by 39
Andersson, A.-C., Lindberg, M., & Lodén, M. (1999) · Journal of Dermatological Treatment · doi:10.3109/09546639909056023 · Cited by 38
Berberian, B. J., Breneman, D., Drake, L. A., Gratton, D., Raimir, S. S., Phillips, S. B., Sulica, V. I., & Bernstein, J. E. (1999) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1999.00505.x · Cited by 35
Zeiger, R. S., & Heller, S. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90191-h · Cited by 35
Topical evening primrose oil as treatment for atopic eczema
Anstey, A. V., QUIGLEY, M. A., & Wilkinson, J. D. (1990) · Journal of Dermatological Treatment · doi:10.3109/09546639009086732 · Cited by 35
Lucky, A. W., Grote, G. D., Williams, J., et al. (1997) · PubMed · Cited by 34
A study of hypoallergenic diets and oral sodium cromoglycate in the management of atopic eczema
Graham, P., Hall‐Smith, S. P., Harris, J. M., et al. (1984) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1984.tb04661.x · Cited by 34
Pyridoxine in atopic dermatitis
Mabin, D. C., Hollis, S., LOCKWOOD, J., & David, T. J. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb02752.x · Cited by 34
Jorizzo, J. L., Levy, M. L., Lucky, A. W., Shavin, J. S., Goldberg, G. N., Dunlap, F. E., Hinds, A., Strelka, L., Baker, M., Tuley, M. R., et al. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90014-4 · Cited by 33
Effects of Linoleic Acid Supplements on Atopic Dermatitis
Giménez‐Arnau, A. M., Barranco, C., Alberola, M. A. T. U., Wale, C. J., Serrano, S., Buchanan, M. R., & Camarasa, J. G. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1810-9_60 · Cited by 30
10% urea cream (Laceran) for atopic dermatitis: A clinical and laboratory evaluation
Pigatto, P., Bigardi, A., Cannistraci, C., & Picardo, M. (1996) · Journal of Dermatological Treatment · doi:10.3109/09546639609086881 · Cited by 30
Habit reversal: a turning point in the treatment of atopic dermatitis
Norén, P. (1995) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1995.tb01273.x · Cited by 29
Pharmacokinetics of doxepin in subjects with pruritic atopic dermatitis
Drake, L. A., Cohen, L. G., Gillies, R. J., Flood, J. G., Riordan, A. T., Phillips, S. B., & Stiller, M. J. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70051-4 · Cited by 29
Businco, L. D. R., Benincori, N., Nini, G., et al. (1986) · PubMed · Cited by 29
Foulds, I. S., & Mackie, R. M. (1981) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1981.tb01600.x · Cited by 27
The morbidity and cost of atopic dermatitis
Herd, R. M. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545771.008 · Cited by 26
Atopic dermatitis in migrant populations
Burrell-Morris, C., & Williams, H. C. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545771.015 · Cited by 24
Breneman, D., DUNLAP, F. E., Monroe, E. W., Schupbach, C. W., Shmunes, E., & Phillips, S. (1997) · Journal of Dermatological Treatment · doi:10.3109/09546639709160512 · Cited by 23
Gammalinolenic acid in the treatment of atopic dermatitis
Valsecchi, R., Landro, A. D., Pansera, B., & Reseghetti, A. (1996) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.1996.tb00562.x · Cited by 20
[Evaluation of the effect of short-term application of deep sea water on atopic dermatitis].
Adachi, J., Sumitsuzi, H., Endo, K., Fukuzumi, T., & Aoki, T. (1998) · PubMed · Cited by 14
[Treatment of atopic dermatitis with borage seed oil (Glandol)--a time series analytic study].
Bahmer, F. A., & Schafer, J. H. (1992) · PubMed · Cited by 13
Cavagni, G., Piscopo, E., Rigoli, E., Iuliano, P. J., Bertolini, P., & Cazzola, P. (1989) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923978909082147 · Cited by 13
Comparison of fluocinonide in a double-blind study with betamethasone valerate.
Binder, R., & McCleary, J. E. (1972) · PubMed · Cited by 13
Shum, Lawton, Williams, H. C., Docherty, & Jones (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03035.x · Cited by 11
Shum, K. W., Lawton, S., Williams, H. C., Docherty, G., & Jones, J. L. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03297.x · Cited by 6
Cited by
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
Guidelines of care for the management of atopic dermatitis
Eichenfield, L. F., Tom, W. L., Chamlin, S. L., Feldman, S. R., Hanifin, J. M., Simpson, E. L., Berger, T. G., Bergman, J. N., Cohen, D. E., Cooper, K. D., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.10.010 · Cited by 1,277
Guidelines of care for the management of atopic dermatitis
Eichenfield, L. F., Tom, W. L., Berger, T. G., Krol, A., Paller, A. S., Schwarzenberger, K., Bergman, J. N., Chamlin, S. L., Cohen, D. E., Cooper, K. D., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.03.023 · Cited by 1,224
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14891 · Cited by 1,181
Quality of life measurement: bibliographic study of patient assessed health outcome measures
Garratt, A., Schmidt, L., Mackintosh, A., & Fitzpatrick, R. (2002) · BMJ · doi:10.1136/bmj.324.7351.1417 · Cited by 1,192
Metadata
- Authors
- Hoare, Po, L. W., & Williams
- Venue
- Health Technology Assessment
- Published
- 2000
- Volume
- 4
- Issue
- 37
- Pages
- 1-191
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W4319293042
- Cited by
- 794
- References
- 123
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.